文献速递腹部泌尿生殖US

超声内镜引导下细针穿刺抽吸可用于排除自身免疫性胰腺炎患者的恶性肿瘤

Endoscopic Ultrasonography-Guided Fine Needle Aspiration Can Be Used to Rule Out Malignancy in Autoimmune Pancreatitis Patients.
PubMed 文献 · J Ultrasound Med · 2017-07-03

本研究回顾性分析40例接受EUS-FNA的自身免疫性胰腺炎患者,其中34例未获组织病理学诊断并随访超过6个月,另选14例EUS-FNA未诊断的胰腺癌患者为对照。结果显示34例自身免疫性胰腺炎患者胰腺肿胀均消退,且主胰管扩张、主胰管直径、包膜样边缘征和血清CA19-9水平在两组间有显著差异。结论认为EUS-FNA可用于排除自身免疫性胰腺炎患者的恶性肿瘤。

要点

  • 自身免疫性胰腺炎患者EUS-FNA未诊断自身免疫性胰腺炎时,随访中胰腺肿胀均可消退。
  • 主胰管扩张(>3 mm)在自身免疫性胰腺炎组仅2.9%,而胰腺癌组达69.2%。
  • 包膜样边缘征在自身免疫性胰腺炎组占79.4%,胰腺癌组为0%。

核心结论

  • 几乎所有胰腺癌均可通过EUS-FNA诊断;EUS-FNA未诊断的胰腺癌与EUS-FNA未诊断的自身免疫性胰腺炎临床特征不同;EUS-FNA可用于排除自身免疫性胰腺炎患者的恶性肿瘤。

研究设计与样本

  • 回顾性研究,纳入40例接受EUS-FNA的自身免疫性胰腺炎患者(1型37例、2型2例、可能自身免疫性胰腺炎1例),其中34例未获组织病理学诊断并随访超过6个月;另选14例EUS-FNA未诊断的胰腺癌患者为对照组,占360例接受EUS-FNA的胰腺癌患者的3.9%。

诊断标准与关键数值

  • 自身免疫性胰腺炎组与胰腺癌组比较:主胰管扩张(>3 mm)分别为2.9%与69.2%(P<.01);主胰管直径分别为1.7±1.6 mm与6.8±5.0 mm(P<.01);包膜样边缘征分别为79.4%与0%(P<.01);血清CA19-9分别为41.4±79.0 U/mL与2079.1±275.3 U/mL(P=.02)。

临床应用与阅片要点

  • 作者认为EUS-FNA可用于排除自身免疫性胰腺炎患者的恶性肿瘤。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to review the suitability of endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) for ruling out malignancy in autoimmune pancreatitis patients.

METHODS: We retrospectively reviewed 40 autoimmune pancreatitis patients (type 1:37 patients; type 2: two patients; possible autoimmune pancreatitis: one patient) who received EUS-FNA. Among the 40 autoimmune pancreatitis patients, 34 were not histopathologically diagnosed with autoimmune pancreatitis by EUS-FNA, and they were followed up for more than 6 months in our hospital. Moreover, 14 pancreatic cancer patients who were not diagnosed by EUS-FNA were selected as a control group. These 14 patients constituted 3.9% of the 360 pancreatic cancer patients who received EUS-FNA. We evaluated the prognoses of the 34 autoimmune pancreatitis patients and the clinical differences between these 34 autoimmune pancreatitis patients and the 14 pancreatic cancer patients.

RESULTS: All 34 autoimmune pancreatitis patients showed reduced pancreatic swelling. The main pancreatic duct dilation ( > 3 mm), the diameter of the main pancreatic duct, the capsule-like rim sign, and serum CA19-9 levels were significantly different between the autoimmune pancreatitis and pancreatic cancer patients (2.9% versus 69.2%, P < .01; 1.7 ± 1.6 mm versus 6.8 ± 5.0 mm, P < .01; 79.4% versus 0%, P < .01; 41.4 ± 79.0 U/mL versus 2079.1 ± 275.3 U/mL, P = .02).

CONCLUSIONS: Almost all pancreatic cancers can be diagnosed by EUS-FNA. Furthermore, other clinical characteristics of pancreatic cancer undiagnosed by EUS-FNA were different from autoimmune pancreatitis undiagnosed by EUS-FNA. Endoscopic ultrasonography-guided FNA can be used to rule out malignancy in autoimmune pancreatitis patients.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Sugimoto M, Takagi T, Suzuki R, et al. Endoscopic Ultrasonography-Guided Fine Needle Aspiration Can Be Used to Rule Out Malignancy in Autoimmune Pancreatitis Patients. J Ultrasound Med. 2017. PMID: 28670760. doi:10.1002/jum.14265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。